Long-term effects of childhood solid tumors and their treatments in survivors
Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000
This study looks at the long-term health and quality of life of childhood cancer survivors treated for solid tumors in France to see how their past treatments affect them now.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 18000 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France Government |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 36 sites (Amiens and 35 other locations) |
| Trial ID | NCT01620372 on ClinicalTrials.gov |
What this trial studies
The French Childhood Cancer Survivor Study (FCCSS) is a large-scale observational study that focuses on children treated for solid tumors in France before the year 2000. It aims to improve understanding of the long-term health and social outcomes of these survivors, including the risk of second malignancies and other health issues related to cancer treatments. The study will follow a cohort of survivors for up to 20 years, utilizing medical records, national registries, and self-questionnaires to gather comprehensive data on their health and quality of life. By identifying high-risk patients and comparing their mortality rates with the general population, the FCCSS seeks to inform better follow-up care and preventive measures.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who were diagnosed with any type of solid childhood cancer in France before the age of 19 between 1942 and 1999.
Not a fit: Patients diagnosed with leukemia will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could lead to improved long-term care and monitoring strategies for childhood cancer survivors, enhancing their quality of life.
How similar studies have performed: Other studies have shown success in understanding long-term effects of childhood cancer treatments, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All types of solid childhood cancer in France * Age at diagnosis: Below age 19 * Period of diagnosis: between 1st January 1942 and 31st December 1999 * Complete identification (first name, last name, date of birth and place of birth) Exclusion Criteria: * Leukaemia cases
Where this trial is running
Amiens and 35 other locations
- Centre Hospital-Universitaire Hôpital Nord — Amiens, France (Active_not_recruiting)
- Centre Hospitalier-Universitaire — Angers, France (Active_not_recruiting)
- Centre Hospitalier Régional Universitaire Hôpital Saint-Jacques — Besançon, France (Active_not_recruiting)
- Groupe hospitalier Pellegrin — Bordeaux, France (Active_not_recruiting)
- Centre Hospitalier Universaitaire Hôpital Côte de Nacre — Caen, France (Active_not_recruiting)
- Centre Hospitalier Universitaire Hôpial Hôtel Dieu — Clermont-Ferrand, France (Active_not_recruiting)
- Centre Hospitalier Universaitaire hôpital d'enfants — Dijon, France (Active_not_recruiting)
- Hôpital La Tronche — Grenoble, France (Active_not_recruiting)
- Centre Oscar Lambret — Lille, France (Active_not_recruiting)
- Hôpital Jeanne De Flandre — Lille, France (Active_not_recruiting)
- Hôpital de la mère et de l'enfant — Limoges, France (Active_not_recruiting)
- Institut d'Hématologie et Oncologie Pédiatrique — Lyon, France (Active_not_recruiting)
- Centre Régional de Lutte Contre le Cancer Centre Léon Bérard — Lyon, France (Active_not_recruiting)
- Hôpital d'Enfants de Margency (HEM) Croix Rouge Française — Margency, France (Active_not_recruiting)
- AP-HM Hôpital de la Timone — Marseille, France (Active_not_recruiting)
- Hôpital Arnaud De Villeneuve — Montpellier, France (Active_not_recruiting)
- Centre Hospitalier Universaitaire Hôpital mère-enfant — Nantes, France (Active_not_recruiting)
- Centre Antoine Lacassagne — Nice, France (Recruiting)
- GCS Hôpitaux pédiatriques Centre Hospitalier Universitaire Lenval — Nice, France (Active_not_recruiting)
- Institut Curie — Paris, France (Recruiting)
- Hôpital Armand Trousseau — Paris, France (Active_not_recruiting)
- CHRU de Poitiers La Miletrie — Poitiers, France (Active_not_recruiting)
- Institut Jean Godinot — Reims, France (Recruiting)
- Centre Hospitalier Universitaire de Reims Hôpital Maison Blanche — Reims, France (Active_not_recruiting)
- Centre Hospitalier Universitaire Hôpital Sud — Rennes, France (Active_not_recruiting)
- Hôpital Charles-Nicolle — Rouen, France (Active_not_recruiting)
- Centre Hospitalier Universitaire Hôpital Nord — Saint-Etienne, France (Active_not_recruiting)
- Centre René Gauducheau de Nantes Atlantique — Saint-Herblain, France (Active_not_recruiting)
- Centre Hospitalier de Saintonge — Saintes, France (Active_not_recruiting)
- Hôpital Hautepierre — Strasbourg, France (Active_not_recruiting)
- Institut Claudius Regaud — Toulouse, France (Recruiting)
- Hôpital des Enfants — Toulouse, France (Active_not_recruiting)
- Hôpital Clocheville — Tours, France (Active_not_recruiting)
- Hôpital Brabois enfants CHU de Nancy — Vandœuvre-lès-Nancy, France (Active_not_recruiting)
- Centre Régional de Lutte Contre le Cancer de Lorraine ALEXIS VAUTRIN — Vandœuvre-lès-Nancy, France (Active_not_recruiting)
- Institut Gustave Roussy — Villejuif, France (Recruiting)
Study contacts
- Principal investigator: Florent F. de Vathaire, Ph.D. — Institut National de la Santé Et de la Recherche Médicale, France
- Study coordinator: Florent F. de Vathaire, Ph.D
- Email: florent.devathaire@igr.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.